The empirical status of melancholia: Implications for psychology
Introduction
Depression has been conceptualized as a heterogeneous mixture of conditions and disorders, but finding meaningful groupings has been a difficult endeavor. The idea of somatogenesis, manifest disease arising from internal biological dysfunction, is at least as old as Hippocrates' writings in the 5th century BC. Melancholia preceded the term depression to describe human despondency. The word is derived from the Greek term “melaina chole” or “black bile,” the bodily humor that was identified with black moods. In recent history, the idea of a somatic genesis for depression has been contrasted with a psychological genesis, and the terms “endogenous” versus “exogenous” or “reactive” have been used to contrast these two sources of depression.
Establishing subgroups of patients based on putative etiology has long been a goal of diagnostic classification. Those with endogenous symptoms should lack precipitating events, although a number of investigators have failed to find group differences in the incidence of stressful life events between individuals with endogenous and non-endogenous symptomatic profiles (e.g., Forrest et al., 1965, Lafer et al., 1996, Leff et al., 1970, Thomson & Hendrie, 1972). In fact, Mundt, Reck, and Backenstrass (2000) demonstrated that stressful experiences often precede onset of melancholic episodes. Findings from other investigations indicate that depressed individuals with melancholic symptomatology may undergo more adverse experiences than non-melancholic individuals (Harkness & Monroe, 2002, Willner et al., 1990). Two studies have provided support for the idea of fewer precipitating events in depressive episodes with endogenous symptoms (e.g., Kohn et al., 2001, Tomaszewska et al., 1996). Overall, the inconsistencies across investigations demonstrate the difficulty in establishing groupings based on supposed etiology.
Section snippets
The constructs of endogeneity and melancholia
The term endogenous has been used to identify a syndrome of depression identified by symptoms of pervasive anhedonia, anorexia, weight loss, early morning awakening, diurnal variation of mood, psychomotor agitation or retardation, guilt, and sometimes psychotic features (Coplov et al., 1986). The grouping of a separate melancholic subtype of depression was introduced in the Diagnostic and Statistical Manual of Mental Disorders, third edition (DSM-III; American Psychiatric Association, 1980).
Biological factors in melancholia
When it was introduced, the dexamethasone suppression test (DST; Carroll, Martin, & Davies, 1968) was offered as a specific laboratory test and biological marker for the presence of melancholia in depression. In normals, dexamethasone suppressed cortisol whereas a non-suppression response, indicative of a pituitary–adrenal hypothalamic dysfunction, was associated with melancholic depression (Carroll et al., 1981). Although these findings were only correlational and could not demonstrate a
Psychological factors in melancholia
A number of assessment techniques have been used to determine whether an individual meets criteria for melancholic depression. The standard for research is to conduct a semistructured interview, such as the Structured Clinical Interview for DSM-IV (First, Spitzer, Gibbon, & Williams, 1995) to obtain both a diagnosis of depression and the specifier “with melancholic features.” While DSM-IV criteria are the most frequently used, expanded criteria were proposed in the Research Diagnostic Criteria
Suicide in melancholic patients
Melancholic patients may have a heightened risk for suicide. Van Praag and Plutchik (1984) studied suicide attempts, depression type, and depression severity in hospital patients with non-psychotic depression. Their data showed that violent suicide attempts occurred with greatest frequency in individuals with melancholic depression. Goldney, Adam, O'Brien, and Termansen (1981) studied 100 female suicide attempters in four Australian inpatient wards and assessed for melancholia. One-third of
Somatic treatment of melancholic depression
There is disagreement about whether melancholic and non-melancholic depressed individuals respond differently to pharmacotherapy and pill placebos. Because of the large number of studies with conflicting data, two papers with alternate viewpoints are cited here. Feinberg (1992) suggested that accurate diagnosis and subtyping of depression is crucial in determining response to treatment. He cited studies demonstrating that melancholic depressed individuals responded to imipramine but not
Psychosocial treatment for melancholic depression
The widespread clinical belief that melancholia should be treated pharmacologically has not been challenged until recently. This notion originally stemmed from older conceptualizations of melancholia as an endogenous disorder. In comparison to the extensive research base on somatic treatments, few studies have examined the efficacy of psychotherapy for melancholic depression. Prusoff, Weissman, Klerman, and Rounsville (1980) were the first to evaluate psychosocial treatments in melancholia.
Summary and conclusions
The proportion of cases with melancholia in an outpatient setting is much lower than non-melancholic forms of depression (Thase & Friedman, 1999). Although it is an uncommon problem, practitioners should be aware that individuals with melancholic symptomatology may require separate assessment tools and the consideration of different treatment options. Unfortunately, there is still debate over what features define melancholia. The DSM-IV specifier “with melancholic features” and RDC of “definite
References (148)
- et al.
Taxonicity of adolescent melancholia: A categorical or dimensional construct?
Journal of Psychiatric Research
(2002) Primary non-endogenous depression and features attributed to reactive depression
Journal of Affective Disorders
(1981)- et al.
Regional brain asymmetries in major depression with or without an anxiety disorder: A quantitative electroencephalographic study
Biological Psychiatry
(1997) - et al.
Outcome with desipramine therapy in subtypes of nonpsychotic depression
Journal of Affective Disorders
(1985) - et al.
The functional anatomy of emotion and affective style
Trends in Cognitive Sciences
(1999) A review of the efficacy and tolerability of venlafaxine
European Psychiatry
(1997)- et al.
Clinical effects of sleep deprivation and clomipramine in endogenous depression
Journal of Psychiatric Research
(1983) - et al.
Depression in young women who have attempted suicide: An international replication study
Journal of Affective Disorders
(1981) - et al.
Increased prevalence of negative life events in subtypes of major depressive disorder
Comprehensive Psychiatry
(2001) - et al.
Outpatients with DSM-III-R versus DSM-IV melancholic depression
Comprehensive Psychiatry
(1996)
Anhedonia in endogenomorphic depression
Psychiatry Research
Depressive psychomotor disturbance, cortisol, and dexamethasone
Biological Psychiatry
Reconfirming the role of life events for the timing of depressive episodes. A two-year prospective follow-up study
Journal of Affective Disorders
The role of the brain reward system in depression
Progress in Neuro-psychopharmacology & Biological Psychiatry
The endogenous subtype and naturalistic course in depression
Journal of Affective Disorders
Dysfunctional parenting: Over-representation in non-melancholic depression and capacity of such specificity to refine sub-typing measures
Psychiatry Research
Parental representations of neurotic and endogenous depressives
Journal of Affective Disorders
Characterological depressions: Clinical and sleep EEG findings separating dysthymias from character spectrum disorders
Archives of General Psychiatry
Diagnostic and statistical manual of mental disorders
Practice guidelines for major depressive disorder in adults
American Journal of Psychiatry
Diagnostic and statistical manual of mental disorders
Efficacy of moclobemide in different patient groups: Results of new subscales of the Hamilton depression rating scale
Clinical Neuropharmacology
Is depression taxonic, dimensional or both?
Journal of Abnormal Psychology
The use of rating scales exemplified by a comparison of the Hamilton and Bech–Rafaelsen Melancholia Scale
Acta Psychiatrica Scandinavica
Cognitive therapy of depression: New perspectives
Cognitive therapy of depression
Manual for the beck depression inventory-II
An inventory for measuring depression
Archives of General Psychiatry
Bipolar II depression with melancholic features
Annals of Clinical Psychiatry
The anatomy of melancholia: Focal abnormalities of cerebral blood flow in major depression
Psychological Medicine
The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry
British Journal of Psychiatry
Predicting depression in women: The role of past and present vulnerability
Psychological Medicine
Factor analytic study of depressive disorders
Journal of Clinical Psychology
The efficacy of cognitive therapy in depression. A treatment trial using cognitive therapy, pharmacotherapy, each alone and in combination
British Journal of Psychiatry
Personality differences between patients with remitted melancholic and non-melancholic depression
American Journal of Psychiatry
Life events and endogenous depression: A puzzle reexamined
Archives of General Psychiatry
Response to dexamethasone and subtype of depression
Archives of General Psychiatry
The diagnosis of depressive syndromes and the prediction of ECT response
British Journal of Psychiatry
Problems with diagnostic criteria for depression
Journal of Clinical Psychiatry
A specific laboratory test for the diagnosis of melancholia
Archives of General Psychiatry
Resistance to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness
British Medical Journal
Presentation of depression and response to group cognitive therapy with older patients
Journal of Clinical Geropsychology
Scales for physical and social anhedonia
Journal of Abnormal Psychology
Personality traits and disorder in depression
American Journal of Psychiatry
Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications
Journal of Abnormal Psychology
Electroencephalographic sleep diagnosis of primary depression
Archives of General Psychiatry
DSM-III Melancholia: Do the criteria accurately and reliably distinguish endogenous pattern depression?
Journal of Affective Disorders
Stressful life events associated with endogenous depression
Journal of Nervous and Mental Disease
Affective style, psychopathology, and resilience: Brain mechanisms and plasticity
American Psychologist
Depression: Perspectives from affective neuroscience
Annual Review of Psychology
Cited by (88)
Changes of cortical thickness in the first episode, drug-naive depression patients with and without melancholic features
2023, Psychiatry Research - NeuroimagingOverlapping and segregated changes of functional hubs in melancholic depression and non-melancholic depression
2022, Journal of Psychiatric ResearchCitation Excerpt :Some studies investigating the disrupted neural function in depression chose to study melancholic patients or other subtypes for controlling the variability and enhancing the consistency of findings(Guo et al., 2015; Soriano-Mas et al., 2011; Vassilopoulou et al., 2013). Melancholic depression, also described as “endogenous” depression, is a relatively common and acknowledged subtype of depression, characterized by symptoms of pervasive anhedonia, unresponsive mood, psychomotor difficulties, early morning awakening, appetite or weight disturbances, and diurnal variation(Leventhal and Rehm, 2005). Melancholic depression has long been correlated to multiple neurobiological factors, such as hypercortisolemia and disturbances in sleep patterns.
Tricyclic antidepressants for treatment-resistant depression
2022, Managing Treatment-Resistant Depression: Road to Novel TherapeuticsMelancholic features in major depression – a European multicenter study
2021, Progress in Neuro-Psychopharmacology and Biological PsychiatryAtypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review
2018, Journal of Affective Disorders